Fig. 1From: Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL studyOverall survival by prior regimens and response. Kaplan–Meier curves according to A prior ASCT status; B prior use of lenalidomide; and C response to prior therapy: PR or CR and failure to reach PR or CRBack to article page